Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Sensitivity resistance to therapy and apoptosis

High level resistance to glucocorticoids, associated with a dysfunctional glucocorticoid receptor, in childhood acute lymphoblastic leukemia cells selected for methotrexate resistance

Abstract

The molecular basis for the clinical presentation of broad-range drug resistance in childhood ALL is poorly understood. In this study, high level cross-resistance to the glucocorticoid dexamethasone was encountered in a childhood ALL cell line selected for resistance to methotrexate (CEM MTX-R3). Compared with wild-type (WT) CEM cells, MTX-R3 cells had significantly fewer glucocorticoid binding sites, as well as reduced glucocorticoid receptor protein and mRNA levels. DNA sequencing and restriction fragment-length polymorphism (RFLP) analysis showed that WT cells expressed both a wild-type and a mutant (GR753F) glucocorticoid receptor allele, while MTX-R3 cells expressed only the GR753F allele. Therefore, the cross-resistance of MTX-R3 cells to dexamethasone appeared due to loss of expression of the wild-type glucocorticoid receptor allele. In an effort to gain insight into the underlying basis for the development of cross-resistance to methotrexate and glucocorticoids, glucocorticoid receptor nuclear translocation experiments were carried out. Exposure of WT cells to either dexamethasone or the cytotoxic agents cytarabine and methotrexate caused translocation of the glucocorticoid receptor from the cytoplasm into the nucleus. These data indicate that exposure of childhood ALL cells to cytotoxic agents may result in ligand-independent glucocorticoid receptor activation which, in the context of the outgrowth of drug-resistant cells, could lead to the co-selection of glucocorticoid resistance.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Gaynon PS, Qu RP, Chappell RJ, Willoughby MLN, Tubergen DG, Steinherz PG, Trigg ME . Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse – the Children's Cancer Group Experience Cancer 1998 82: 1387–1395

    Article  CAS  Google Scholar 

  2. Klumper E, Pieters R, Veerman AJP, Huismans DR, Loonen AH, Hählen K, Kaspers GJL, van Wering ER, Hartmann R, Henze G . In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia Blood 1995 86: 3861–3868

    CAS  PubMed  Google Scholar 

  3. Wolff C, Brubaker M, Murphy M, Pierce M, Severo N . Prednisone therapy of acute childhood leukemia: prognosis and duration of response in 330 treated patients J Pediat 1967 70: 626–631

    Article  CAS  Google Scholar 

  4. Pfahl M, Kelleher RJ Jr, Bourgeois S . General features of steroid resistance in lymphoid cell lines Mol Cell Endocrinol 1978 10: 193–207

    Article  CAS  Google Scholar 

  5. Foley GE, Lazarus H, Farber S, Uzman BG, Boone BA, McCarthy RE . Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia Cancer 1965 18: 522–529

    Article  CAS  Google Scholar 

  6. Powers JH, Hillmann AG, Tang DC, Harmon JM . Cloning and expression of mutant glucocorticoid receptors from glucocorticoid-sensitive and resistant human leukemic cells Cancer Res 1993 53: 4059–4065

    CAS  PubMed  Google Scholar 

  7. Ashraf J, Thompson EB . Identification of the activation-labile gene: a single point mutation in the human glucocorticoid receptor presents as two distinct receptor phenotypes Mol Endocrinol 1993 7: 631–642

    CAS  PubMed  Google Scholar 

  8. Strasser-Wozak EM, Hattmannstorfer R, Hála M, Hartmann BL, Fiegl M, Geley S, Kofler R . Splice site mutation in the glucocorticoid receptor gene causes resistance to glucocorticoid-induced apoptosis in a human acute leukemic cell line Cancer Res 1995 55: 348–353

    CAS  PubMed  Google Scholar 

  9. Hala M, Hartmann BL, Bock G, Geley S, Kofler R . Glucocorticoid-receptor-gene defects and resistance to glucocorticoid-induced apoptosis in human leukemic cell lines Int J Cancer 1996 68: 663–668

    Article  CAS  Google Scholar 

  10. Geley S, Hartmann BL, Hala M, Strasser-Wozak EM, Kapelari K, Kofler R . Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression Cancer Res 1996 56: 5033–5038

    CAS  PubMed  Google Scholar 

  11. Palmer LA, Harmon JM . Biochemical evidence that glucocorticoid-sensitive cell lines derived from the human leukemic cell line CCRF-CEM express a normal and a mutant glucocorticoid receptor gene Cancer Res 1991 51: 5224–5231

    CAS  PubMed  Google Scholar 

  12. Haber M, Reed C, Kavallaris M, Norris MD, Stewart BW . Resistance to drugs associated with the multidrug resistance phenotype following selection with high-concentration methotrexate J Natl Cancer Inst 1989 81: 1250–1254

    Article  CAS  Google Scholar 

  13. Borsi JD, Moe PJ . A comparative study of the pharmacokinetics of methotrexate in a dose range of 0.5 g to 33.6 g/m2 in children with acute lymphoblastic leukemia Cancer 1987 60: 5–13

    Article  CAS  Google Scholar 

  14. Kavallaris M, Haber M, Norris MD, Matherly LH, Stewart BW . Characterization of mechanisms mediating drug resistance in human leukemic cells selected with high concentration methotrexate Pteridines 1992 3: 119–121

    CAS  Google Scholar 

  15. Norris MD, De Graaf D, Haber M, Kavallaris M, Madafiglio J, Gilbert J, Kwan E, Stewart BW, Mechetner EB, Gudkov AV, Roninson IB . Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexate Int J Cancer 1996 65: 613–619

    Article  CAS  Google Scholar 

  16. Gifford AJ, Kavallaris M, Madafiglio J, Matherly LH, Stewart BW, Haber M, Norris MD . P-glycoprotein-mediated methotrexate resistance in CCRF-CEM sublines deficient in methotrexate accumulation due to a point mutation in the reduced folate carrier gene Int J Cancer 1998 78: 176–181

    Article  CAS  Google Scholar 

  17. Scatchard G . The attractions of proteins for small molecules and ions Ann NY Acad Sci 1949 51: 660–672

    Article  CAS  Google Scholar 

  18. Harmon JM, Thompson EB . Isolation and characterization of dexamethasone-resistant mutants from human lymphoid cell line CEM-C7 Mol Cell Biol 1981 1: 512–521

    Article  CAS  Google Scholar 

  19. Harmon JM, Schmidt TJ, Thompson EB . Molybdate-sensitive and molybdate-resistant activation-labile glucocorticoid-receptor mutants of the human lymphoid cell line CEM-C7 J Steroid Biochem 1984 21: 227–236

    Article  CAS  Google Scholar 

  20. Bradford MM . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 1976 72: 248–254

    Article  CAS  Google Scholar 

  21. Smets L, Salomons G, van Rooij H, van den Berg J . Involvement of the glucocorticoid receptor in stress-induced apoptosis of leukemic cells Leukemia 1998 12: 406–413

    Article  CAS  Google Scholar 

  22. Murphy KM, Streips UN, Lock RB . Bax membrane insertion during Fas(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2 Oncogene 1999 18: 5991–5999

    Article  CAS  Google Scholar 

  23. Murphy KM, Streips UN, Lock RB . Bcl-2 inhibits a Fas-induced conformational change in the Bax N terminus and Bax mitochondrial translocation J Biol Chem 2000 275: 17225–17228

    Article  CAS  Google Scholar 

  24. Sambrook J, Fritsch EJ, Maniatis T . Molecular cloning: A Laboratory Manual, 2nd edn, Cold Spring Harbor Laboratory Press: New York 1989

    Google Scholar 

  25. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM . Primary structure and expression of a functional human glucocorticoid receptor cDNA Nature 1985 318: 635–641

    Article  CAS  Google Scholar 

  26. Palmer LA, Hukku B, Harmon JM . Human glucocorticoid receptor gene deletion following exposure to cancer chemotherapeutic drugs and chemical mutagens Cancer Res 1992 52: 6612–6618

    CAS  PubMed  Google Scholar 

  27. Norman MR, Thompson EB . Characterization of a glucocorticoid-sensitive human lymphoid cell line Cancer Res 1977 37: 3785–3791

    CAS  PubMed  Google Scholar 

  28. Ercolani L, Florence B, Denaro M, Alexander M . Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene J Biol Chem 1988 263: 15335–15341

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the Children's Cancer Institute Australia for Medical Research, which is affiliated with the University of New South Wales and Sydney Children's Hospital.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Catts, V., Farnsworth, M., Haber, M. et al. High level resistance to glucocorticoids, associated with a dysfunctional glucocorticoid receptor, in childhood acute lymphoblastic leukemia cells selected for methotrexate resistance. Leukemia 15, 929–935 (2001). https://doi.org/10.1038/sj.leu.2402128

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402128

Keywords

This article is cited by

Search

Quick links